OBJECTIVES: Many patients with osteoarthritis have comorbid symptoms of FM, but it is unknown how these symptoms respond to surgical procedures that address nociceptive input in the periphery, such as total joint replacement. Here we explore differences in clinical characteristics between patients whose FM symptoms do and do not improve following total hip or knee replacement. METHODS: Participants were 150 patients undergoing knee or hip replacement who had a minimum FM survey score of 4 or greater prior to surgery. The top tertile of patients experiencing the most improvement in FM symptoms at month 6 were categorized as 'Improve' (n = 48) while the bottom two tertiles were categorized as 'Worsen/Same' (n = 102). Baseline symptom characteristics were compared between groups, as well as improvement in overall pain severity, surgical pain severity and physical function at 6 months. RESULTS: The Worsen/Same group had higher levels of fatigue, depression and surgical site pain at baseline (all P < 0.05). Additionally, they improved less on overall pain severity and physical functioning 6 months after surgery (both P < 0.05). CONCLUSION: Most patients derive significant benefit in improvement of comorbid FM symptoms following total joint replacement, but a substantial proportion do not. Understanding the neurobiological basis for these different trajectories may help inform clinical judgment and improve patient care.
OBJECTIVES: Many patients with osteoarthritis have comorbid symptoms of FM, but it is unknown how these symptoms respond to surgical procedures that address nociceptive input in the periphery, such as total joint replacement. Here we explore differences in clinical characteristics between patients whose FM symptoms do and do not improve following total hip or knee replacement. METHODS:Participants were 150 patients undergoing knee or hip replacement who had a minimum FM survey score of 4 or greater prior to surgery. The top tertile of patients experiencing the most improvement in FM symptoms at month 6 were categorized as 'Improve' (n = 48) while the bottom two tertiles were categorized as 'Worsen/Same' (n = 102). Baseline symptom characteristics were compared between groups, as well as improvement in overall pain severity, surgical pain severity and physical function at 6 months. RESULTS: The Worsen/Same group had higher levels of fatigue, depression and surgical site pain at baseline (all P < 0.05). Additionally, they improved less on overall pain severity and physical functioning 6 months after surgery (both P < 0.05). CONCLUSION: Most patients derive significant benefit in improvement of comorbid FM symptoms following total joint replacement, but a substantial proportion do not. Understanding the neurobiological basis for these different trajectories may help inform clinical judgment and improve patient care.
Authors: Michael E Geisser; Jennifer M Glass; Ljubinka D Rajcevska; Daniel J Clauw; David A Williams; Paul R Kileny; Richard H Gracely Journal: J Pain Date: 2008-02-15 Impact factor: 5.820
Authors: Michael E Geisser; Cathy Strader Donnell; Frank Petzke; Richard H Gracely; Daniel J Clauw; David A Williams Journal: Psychosomatics Date: 2008 May-Jun Impact factor: 2.386
Authors: Chad M Brummett; Allison M Janda; Christa M Schueller; Alex Tsodikov; Michelle Morris; David A Williams; Daniel J Clauw Journal: Anesthesiology Date: 2013-12 Impact factor: 7.892
Authors: Richard E Harris; Vitaly Napadow; John P Huggins; Lynne Pauer; Jieun Kim; Johnson Hampson; Pia C Sundgren; Bradley Foerster; Myria Petrou; Tobias Schmidt-Wilcke; Daniel J Clauw Journal: Anesthesiology Date: 2013-12 Impact factor: 7.892
Authors: Lesley M Arnold; James I Hudson; Evelyn V Hess; Avis E Ware; Deborah A Fritz; Megan B Auchenbach; Linsey O Starck; Paul E Keck Journal: Arthritis Rheum Date: 2004-03
Authors: Marina López-Solà; Jesus Pujol; Tor D Wager; Alba Garcia-Fontanals; Laura Blanco-Hinojo; Susana Garcia-Blanco; Violant Poca-Dias; Ben J Harrison; Oren Contreras-Rodríguez; Jordi Monfort; Ferran Garcia-Fructuoso; Joan Deus Journal: Arthritis Rheumatol Date: 2014-11 Impact factor: 10.995
Authors: Andrew Schrepf; Chelsea M Kaplan; Eric Ichesco; Tony Larkin; Steven E Harte; Richard E Harris; Alison D Murray; Gordon D Waiter; Daniel J Clauw; Neil Basu Journal: Nat Commun Date: 2018-06-08 Impact factor: 14.919